merck

Palantir Technologies Inc. (NYSE: PLTR) is in the sweet spot of the heightened interest in companies involved in digital transformation. This is reflected in a slew of partnerships the company recently disclosed. What Happened: Palantir announced the renewal of a strategic...

Novamind Strikes Research Deal With Merck Psychedelics company Novamind (PINK: NVMDF) announced a subsidiary has been selected as a research site for a clinical trial of a compound developed by pharma giant Merck (NYSE: MRK). The phase II trial will assess the efficacy and safety of MK-1942,...

This weekend's Barron's cover story shares thoughts from a panel of experts on what to expect for stocks in 2021. Other featured articles examine Barron's picks for 2021, the preliminary 2021 Dogs of the Dow, and whether dividends and buybacks are about to rebound. Also, the prospects...

This weekend's Barron's suggests ways to play U.S.-China tensions and the stock-splitting trend. Other featured articles look at how the election could affect health care stocks and what to expect from big-box retail earnings. Also, the prospects for a pharmaceutical giant, regional bank...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included pharmaceutical and ride-share leaders. The e-commerce colossus and the iPhone maker were among the week's bearish calls. A July employment report that was better...

COVID-19 coronavirus made us realize that health should always be our top priority. Here are some companies working to make the world a better place after the pandemic.  AbbVie Inc – Botox To The Rescue With unappreciated potential, the stock of this big drugmaker has stellar...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. At a time when markets are more volatile than at any point since the 2008 financial crisis, it’s critically important for company...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included a big-box retailer and a package delivery giant. Bearish calls included a leading pharmaceutical maker and an Apple supplier. For the second time in a row, the major U.S. indexes...

This weekend's Barron's cover story reveals the third annual ranking of America's most sustainable companies. Other featured articles explain why oil stocks may have hit bottom and offer a look at how the coronavirus outbreak is affecting health care companies. Also, the prospects for...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included an underappreciated automaker and a leading pharmaceutical. Bearish calls included FAANG stocks and an aerospace giant. Healthy earnings reports from sector leaders like Apple,...

This weekend's Barron's cover story examines a way to outsmart the dimming prospects for corporate profits. Other featured articles offer how to play pharmaceuticals and why not to abandon quality stocks. Also, the prospects for a commercial property owner and an optical products giant....

Pharmaceutical giants Bristol-Myers Squibb Co (NYSE: BMY) and Merck & Co., Inc. (NYSE: MRK) both release their second quarter earnings reports this week. According to BMO Capital, investors should be buying Merck and selling Bristol-Myers ahead of earnings. Despite Merck being on the verge of...

This weekend's Barron's takes a look at six undervalued energy stocks and five ways to play the new gold rally. Other featured articles offer the prospects for a medical device maker with a breakthrough product and an underappreciated investment manager. Also, a top fund manager...

The two pharmaceutical Dow components are expected to report earnings this week. Both of them are expected to show a decline in earnings from a year ago. Also, they both tend to exceed consensus earnings estimates. Most of the Dow Jones Industrial Average components have already...

More than a third of the Dow components are expected to report earnings this week. Only a health care giant and an oil supermajor are expected to show solid growth on both the top and bottom lines. Both have beat earnings expectations in recent quarters. We are in the heart of the fourth-quarter...